Spyroulias GA - Search Results

1

Richichi B, Spyroulias GA, Winum JY, Žalubovskis R. Richichi B, et al. Among authors: spyroulias ga. Curr Med Chem. 2019;26(15):2556-2557. doi: 10.2174/092986732615190725122012. Curr Med Chem. 2019. PMID: 31453777

2

Conformational properties of HIV-1 gp120/V3 immunogenic domains.

Galanakis PA, Spyroulias GA, Rizos A, Samolis P, Krambovitis E. Galanakis PA, et al. Among authors: spyroulias ga. Curr Med Chem. 2005;12(13):1551-68. doi: 10.2174/0929867054038982. Curr Med Chem. 2005. PMID: 15974987 Review.

3

Pyrrolo[2,3-a]carbazoles as potential cyclin dependent kinase 1 (CDK1) Inhibitors. Synthesis, biological evaluation, and binding mode through docking simulations.

Fousteris MA, Papakyriakou A, Koutsourea A, Manioudaki M, Lampropoulou E, Papadimitriou E, Spyroulias GA, Nikolaropoulos SS. Fousteris MA, et al. Among authors: spyroulias ga. J Med Chem. 2008 Feb 28;51(4):1048-52. doi: 10.1021/jm0700666. Epub 2008 Jan 31. J Med Chem. 2008. PMID: 18232654

4

Therapeutic Targeting of the Soluble Guanylate Cyclase.

Makrynitsa GI, Zompra AA, Argyriou AI, Spyroulias GA, Topouzis S. Makrynitsa GI, et al. Among authors: spyroulias ga. Curr Med Chem. 2019;26(15):2730-2747. doi: 10.2174/0929867326666190108095851. Curr Med Chem. 2019. PMID: 30621555 Review.

5

Structural features of angiotensin-I converting enzyme catalytic sites: conformational studies in solution, homology models and comparison with other zinc metallopeptidases.

Spyroulias GA, Galanis AS, Pairas G, Manessi-Zoupa E, Cordopatis P. Spyroulias GA, et al. Curr Top Med Chem. 2004;4(4):403-29. doi: 10.2174/1568026043451294. Curr Top Med Chem. 2004. PMID: 14965309 Review.

6

Putative bioactive conformations of amide linked cyclic myelin basic protein peptide analogues associated with experimental autoimmune encephalomyelitis.

Spyranti Z, Dalkas GA, Spyroulias GA, Mantzourani ED, Mavromoustakos T, Friligou I, Matsoukas JM, Tselios TV. Spyranti Z, et al. Among authors: spyroulias ga. J Med Chem. 2007 Nov 29;50(24):6039-47. doi: 10.1021/jm070770m. Epub 2007 Nov 3. J Med Chem. 2007. PMID: 17979262

7

Low molecular weight inhibitors of the protease anthrax lethal factor.

Dalkas GA, Papakyriakou A, Vlamis-Gardikas A, Spyroulias GA. Dalkas GA, et al. Among authors: spyroulias ga. Mini Rev Med Chem. 2008 Mar;8(3):290-306. doi: 10.2174/138955708783744083. Mini Rev Med Chem. 2008. PMID: 18336349 Review.

8

Insights into soluble guanylyl cyclase activation derived from improved heme-mimetics.

Rekowski MVW, Kumar V, Zhou Z, Moschner J, Marazioti A, Bantzi M, Spyroulias GA, van den Akker F, Giannis A, Papapetropoulos A. Rekowski MVW, et al. Among authors: spyroulias ga. J Med Chem. 2013 Nov 14;56(21):8948-8952. doi: 10.1021/jm400539d. Epub 2013 Oct 24. J Med Chem. 2013. PMID: 24090476 Free PMC article.

9

A computational approach to the study of the binding mode of dual ACE/NEP inhibitors.

Dimitropoulos N, Papakyriakou A, Dalkas GA, Sturrock ED, Spyroulias GA. Dimitropoulos N, et al. Among authors: spyroulias ga. J Chem Inf Model. 2010 Mar 22;50(3):388-96. doi: 10.1021/ci9005047. J Chem Inf Model. 2010. PMID: 20170101

10

Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE).

Asimakopoulou A, Panopoulos P, Chasapis CT, Coletta C, Zhou Z, Cirino G, Giannis A, Szabo C, Spyroulias GA, Papapetropoulos A. Asimakopoulou A, et al. Among authors: spyroulias ga. Br J Pharmacol. 2013 Jun;169(4):922-32. doi: 10.1111/bph.12171. Br J Pharmacol. 2013. PMID: 23488457 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page